Best Stocks To Buy May 2015 Investment News Show

Best Stocks To Buy May 2015

The May 12 show featured a live interview with

Immune Therapeutics Inc.

(Stock Symbol: IMUN),

CEO Noreen Griffin


Dr. Gloria Herndon discussed her work with Immune Therapeutics, Inc. 

Listen to a replay of Part 1 of the show:


Listen to a replay of Part 2 of the show with Noreen Griffin of Immune Therapeutics, Inc. interview:

Undervalued Medical Stocks May 2015


Get IMUN stock quote and latest news – Click Here IMUN

Visit The Corporate Site —

See Corporate Investors Information and stock quote page:
Click Here

small cap medical stock

Mrs. Herndon will discuss her work with Immune Therapeutics to combat a variety of chronic, life-threatening diseases.

See more on Mrs. Herndon and her work:

Unsung Heroine: Dr. Gloria Herndon — See The Huffington Post Article

Immune Therapeutics is a specialty pharmaceutical company undergoing a wide range of FDA testing of therapeutic protocols preparatory to the manufacture, commercialization, marketing, and distribution of their patented therapies.

Their novel concepts entail enhancing and refining both the activation and modulation of the body’s natural immune system.

The biotechnology company working to combat chronic, life-threatening diseases through the activation and modulation of the body’s immune system using our patented immunotherapy.

Their Products and immunotherapy technologies are designed to harness the power of the immune system to improve the treatment of cancer, infections such as HIV/AIDS, chronic inflammatory diseases, and autoimmune diseases.

The company’s therapies have been demonstrated over time to be highly efficacious and virtually free of side negative effects.

Small Cap Medical Stock News

Immune Therapeutics Inc, Announces the official publication announcement of the NAFDAC approved 90-Day Bridging Trial of Lodonal™ with HIV/AIDS Patients.

Immune Therapeutics Inc – Lodonal™ an Adjunct Immune Therapy for Treatment of Patients with HIV/AIDS

ORLANDO, Fla. and DUBLIN, May 4, 2015/PRNewswire/ — Immune Therapeutics Inc (IMUN) “Immune Therapeutics”, through its fully owned subsidiary, TNI Biotech International, today announced the dosing of the first patient with Lodonal™ (Once-daily OralTreatment) for the 90-Day bridging clinical trial of Immune Therapeutics’ proprietary patented therapy (Lodonal™) as an adjunct  treatment for HIV/AIDS and opportunistic infections. — See More


Immune Therapeutics Inc. CEO Issues Letter to Shareholders Highlighting Significant Progress — See News


Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. — See News

Money Info Show Airs

10 AM to 11 AM EDT

Every Tuesday

Investment News Show


Use this Link To Watch The Show:

Be On The Air With Us
Call In Your Questions

Money Info

The Princeton Research Money Info show features where to invest now, stock market, business, economy and financial investment news.

The show is broadcast live on the internet and on the air  from the studios of Radio Station WPSL AM 1590, Port St. Lucie, Florida — The Talk of the Treasure Coast 

Money Info is hosted by investing experts Mike King and Charles Moskowitz together with radio broadcasting professional Greg Wyatt.

Small cap stocks to buy

Small Cap Stocks To Buy

Stocks to Buy May 2015